Scientia Vascular
Scientia Vascular: Providing optimized devices and therapies for evolving interventional needs.
Founded
2007Scientia Vascular: Providing optimized devices and therapies for evolving interventional needs.
Founded with a mission to advance neurovascular innovation, Scientia Vascular provides specialized access devices and therapies tailored to meet the evolving needs of interventional specialists. Their product lineup includes the Aristotle series of guidewires and the Socrates and Plato series of microcatheters and aspiration catheters, all designed to enhance precision and efficacy in medical procedures. The company focuses on delivering high-quality solutions that support healthcare professionals in achieving better patient outcomes.
Scientia Vascular has garnered attention from notable investors and industry experts, contributing to its rapid growth and recognition in the medical device sector. The company's key achievements include the successful development and deployment of cutting-edge neurovascular devices that have set new standards in the field. Through continuous innovation and a commitment to excellence, Scientia Vascular has made a significant impact on improving interventional medical practices and patient care globally.
Companies similar to Scientia Vascular include Q'Apel Medical, Vascugenix, Spartan Micro and NeuroVasc Technologies.
Scientia Vascular was founded in 2007.
Scientia Vascular's headquarters is located in West Valley City, UT, US.
Scientia Vascular's most recent funding round was for $5M (USD) in November 2023.
As of Nov 28, 2023, Scientia Vascular has disclosed funding of $80M (USD). Undisclosed round amounts are excluded.
Scientia Vascular has 122 employees as of Feb 5, 2024.
NeuroVasc Technologies
